Company Filing History:
Years Active: 2010-2019
Title: Hsien-Yeh Hsu: Innovator in Cancer Treatment
Introduction
Hsien-Yeh Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 4 patents, Hsu's work focuses on utilizing natural compounds for therapeutic applications.
Latest Patents
Hsien-Yeh Hsu's latest patents include groundbreaking developments in immunogenic compositions and cancer vaccines. One notable patent describes antibody-mediated anti-tumor activity induced by Reishi mushroom polysaccharides. This invention provides immunogenic compositions and methods for treating cancer that comprise FMS, the fucose-enriched polysaccharide fraction from Reishi F3. The compositions include a fucose-enriched Reishi polysaccharide fraction (FMS) with a molecular weight of approximately 35 kDa, isolated by size-exclusion chromatography. The FMS comprises polysaccharides with a backbone primarily selected from 1,4-mannan and 1,6-α-galactan, linked to a terminal fucose-containing side-chain. Additionally, the immunogenic compositions disclosed generate antibodies that bind to cancer cells with specific antigens, including Globo H and SSEA-4. Another patent focuses on a method for treating refractory or relapsed lung cancer, utilizing an immunomodulatory protein derived from natural sources.
Career Highlights
Hsien-Yeh Hsu has worked with esteemed organizations such as Academia Sinica and Mycomagic Biotechnology Co., Ltd. His research has significantly advanced the understanding of cancer treatment and the potential of natural compounds in therapeutic applications.
Collaborations
Hsien-Yeh Hsu has collaborated with notable colleagues, including Chi-Huey Wong and Tung-Yi Lin. These partnerships have fostered innovation and contributed to the success of his research endeavors.
Conclusion
Hsien-Yeh Hsu's contributions to cancer treatment through his innovative patents highlight the potential of natural compounds in medical applications. His work continues to inspire advancements in the field of oncology.